Baudette, 56623, MN,
United States
ANI Pharmaceuticals Technographics
ANI Pharmaceuticals Technographics, Software Purchases, AI and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by ANI Pharmaceuticals and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 642 ANI Pharmaceuticals employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that ANI Pharmaceuticals has purchased the following applications: Microsoft 365 for Collaboration in 2017, Cisco Umbrella for Secure Web Gateways (SWG) in 2022 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems ANI Pharmaceuticals is running and its propensity to invest more and deepen its relationship with Microsoft , Cisco Systems or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing ANI Pharmaceuticals revenues, which have grown to $486.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for ANI Pharmaceuticals intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
ANI Pharmaceuticals Tech Stack and Enterprise Applications
ANI Pharmaceuticals Collaboration
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Microsoft | Legacy | Microsoft 365 | Collaboration | Collaboration | n/a | 2017 | 2017 |
In 2017, ANI Pharmaceuticals implemented Microsoft 365 as its primary Collaboration platform. The company publicly references Microsoft 365 on its website, indicating adoption of Microsoft 365 for core collaboration and productivity services across the organization. The deployment reflects a cloud-first Microsoft 365 tenant approach, positioned to centralize email, document collaboration, and meeting workflows for corporate users.
Microsoft 365 implementation at ANI Pharmaceuticals is consistent with standard Collaboration capabilities, including Exchange Online for messaging, Microsoft Teams for real-time collaboration, SharePoint Online for intranet and document management, and OneDrive for user file storage. The configuration also aligns with cloud identity and access controls via Azure Active Directory and device and policy management patterns common to Microsoft 365 deployments, which supports governance around information classification and conditional access. Operational scope includes corporate collaboration and cross-functional workflows in a life sciences environment, with centralized administration and policy controls to standardize communication and document lifecycle management.
|
ANI Pharmaceuticals CyberSecurity
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Cisco Systems | Legacy | Cisco Umbrella | Secure Web Gateways (SWG) | CyberSecurity | n/a | 2022 | 2022 |
In 2022, ANI Pharmaceuticals implemented Cisco Umbrella as its Secure Web Gateways (SWG) solution to strengthen DNS layer protection across its IT environment. The deployment was led from the company site in Baudette, MN and was driven by an internal recognition of security and management gaps that required rapid tooling and policy work.
Cisco Umbrella was implemented specifically for DNS protection, with deployment activities focused on DNS layer enforcement and web filtering capabilities common to Secure Web Gateways (SWG). The implementation narrative records the use of Cisco Umbrella DNS protection as the primary SWG signal, aligned with standard category functions such as domain level blocking, threat intelligence ingestion, and policy-based content controls.
The Umbrella deployment was executed alongside other security and operational initiatives including Microsoft 365 Multi Factor Authentication and an Arctic Wolf security deployment, while NinjaOne was implemented for endpoint management. Operational workstreams concurrently included Windows server management activities, migration of file servers to newer operating systems, domain controller replacements, VMware host management, and HP SAN management, indicating coordination across IT operations and security teams.
Governance and rollout were driven by project management from a senior IT analyst role, and included development of information security policy to institutionalize controls introduced by Cisco Umbrella and companion tools. The implementation is described as part of a broader effort to address identified security and management gaps, with responsibility and ongoing management falling to ANI Pharmaceuticals IT and security operations.
|
IT Decision Makers and Key Stakeholders at ANI Pharmaceuticals
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| No data found | ||||||
Apps Being Evaluated by ANI Pharmaceuticals Executives
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||